| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3819116 | La Presse Médicale | 2016 | 4 Pages |
Abstract
SummaryThe use of rituximab in Graves’ orbitopathy is appealing but its exact role in the therapeutic arsenal remains to be clarified, and its safety profile also needs to be confirmed on a larger scale.
Related Topics
Health Sciences
Medicine and Dentistry
Medicine and Dentistry (General)
Authors
Miriam Ladsous,